LGND Capital Expenditure
Ligand Pharmaceuticals Inc · Capital Expenditure
LGND Capital Expenditure
Latest reported-$278.00Kperiod ending
LGND CapEx (-$600.00K → -$278.00K)
Annual CapEx
High-resolution chart · PNG
LGND capital expenditure history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Capital Expenditure (USD) |
|---|---|
| -452,000 | |
| -19,640,000 | |
| -53,849,000 | |
| -17,923,000 | |
| -8,761,000 | |
| -4,458,000 | |
| -2,553,000 | |
| -11,887,000 | |
| -7,154,000 | |
| -28,322,000 | |
| -10,863,000 | |
| -4,499,000 | |
| -4,937,000 | |
| -8,644,000 | |
| -78,000 | |
| -70,000 | |
| -522,000 | |
| -495,000 | |
| -440,000 | |
| -1,783,000 | |
| -35,596,000 | |
| -3,604,000 | |
| -2,783,000 | |
| -3,161,000 | |
| -1,974,000 | |
| -1,085,000 | |
| -39,500,000 | |
| -2,400,000 | |
| -4,300,000 | |
| -400,000 | |
| -200,000 | |
| -600,000 |